Inozyme Pharma OverviewInozyme Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for INZY.
Quarterly EBIT
-$26.63M
↓ 8.59% YoY
As of Mar 31, 2025
Annual EBIT (TTM)
-$105.00M
↓ 28.03% YoY
Trailing 12 months ending Mar 31, 2025
Inozyme Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for INZY.
As of Mar 31, 2025
Trailing 12 months ending Mar 31, 2025